- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: N.61
- Chain E: N.74, S.75
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.122, V.127, W.152
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.278, N.280
Ligand excluded by PLIPNAG.7: 4 residues within 4Å:- Chain A: Q.115, E.132, N.163, T.165
Ligand excluded by PLIPNAG.8: 2 residues within 4Å:- Chain A: N.329, Q.578
Ligand excluded by PLIPNAG.9: 1 residues within 4Å:- Chain A: N.601
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain A: H.653, V.654, N.655
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.715, Q.924, Q.1069
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain A: N.799, S.801
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain A: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: N.1096, T.1098, H.1099, F.1101
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.1132
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.614, T.616
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.707, G.1129
- Chain K: D.794
Ligand excluded by PLIPNAG.18: 7 residues within 4Å:- Chain A: T.114, Q.115, I.231, N.232
- Chain D: R.30, Y.32
- Chain E: R.103
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain F: N.61
- Chain J: N.74, S.75
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain F: N.122, V.127, W.152
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain F: N.278, N.280
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain F: Q.115, E.132, N.163, T.165
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain F: N.329, Q.578
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain F: N.601
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain F: H.653, V.654, N.655
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain F: N.715, Q.924, Q.1069
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain F: N.799, S.801
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain F: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain F: N.1096, T.1098, H.1099, F.1101
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain F: N.1132
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain F: N.614, T.616
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: D.794
- Chain F: N.707, G.1129
Ligand excluded by PLIPNAG.33: 7 residues within 4Å:- Chain F: T.114, Q.115, I.231, N.232
- Chain I: R.30, Y.32
- Chain J: R.103
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain K: N.61
- Chain O: N.74, S.75
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain K: N.122, V.127, W.152
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain K: N.278, N.280
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain K: Q.115, E.132, N.163, T.165
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain K: N.329, Q.578
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain K: N.601
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain K: H.653, V.654, N.655
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain K: N.715, Q.924, Q.1069
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain K: N.799, S.801
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain K: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain K: N.1096, T.1098, H.1099, F.1101
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain K: N.1132
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain K: N.614, T.616
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain F: D.794
- Chain K: N.707, G.1129
Ligand excluded by PLIPNAG.48: 7 residues within 4Å:- Chain K: T.114, Q.115, I.231, N.232
- Chain N: R.30, Y.32
- Chain O: R.103
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCallum, M. et al., Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-11-17
- Peptides
- Spike glycoprotein: AFK
S2M11 Fab light chain: BGL
S2M11 Fab heavy chain: CHM
S2L20 Fab light chain: DIN
S2L20 Fab heavy chain: EJO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
FK
KB
DG
GL
LC
EH
HM
MD
BI
IN
NE
CJ
JO
O
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCallum, M. et al., Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-11-17
- Peptides
- Spike glycoprotein: AFK
S2M11 Fab light chain: BGL
S2M11 Fab heavy chain: CHM
S2L20 Fab light chain: DIN
S2L20 Fab heavy chain: EJO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
FK
KB
DG
GL
LC
EH
HM
MD
BI
IN
NE
CJ
JO
O